Novogen’s drug destroys ovarian cancer stem cell tumours – Proactive Investors Australia
| Proactive Investors Australia Novogen’s US subsidiary CanTx, in conjunction with Yale University, has shown that cancer stem cells isolated from the tumors of ovarian cancer patients are able to form self-renewing spheroids. When injected into a mouse model, these spheroids form … Trilexium Destroys Ovarian Cancer Stem Cell Spheroidsirasia.com (press release) |
